Repositrak, Inc. (TRAK) - 10-K Summary
Business Context and Reporting Period
Company: ReposiTrak, Inc. (formerly Park City Group, Inc.)
Filing Type: Annual Report on Form 10-K
Reporting Period: Fiscal Year ended June 30, 2024
Business Model: SaaS provider of B2B e-commerce, compliance, traceability, and supply chain management platforms. The company operates a "hub and spoke" model, engaging retailers/wholesalers (Hubs) who mandate suppliers (Spokes) to use the platform.
Key Products: Compliance Management, Traceability Network (RTN), and Supply Chain Solutions.
Key Financial Metrics (Fiscal Year Ended June 30, 2024)
| Metric | 2024 | 2023 |
|---|---|---|
| Revenue | $20,453,320 | $19,098,910 |
| Net Income | $5,958,290 | $5,590,289 |
| Net Income (Common Shareholders) | $5,408,645 | $5,003,845 |
| Diluted EPS | $0.29 | $0.27 |
| Operating Cash Flow | $6,964,401 | $8,860,019 |
| Cash & Equivalents (End of Period) | $25,153,862 | $23,990,879 |
| Working Capital | $24,757,025 | $23,042,199 |
| Bank Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 7% ($1.35M) driven by growth in recurring subscription revenue across compliance, supply chain, and traceability lines.
- Profitability: Net income increased 7% ($368K). Operating income decreased slightly to $5.02M from $5.09M due to higher operating expenses, but was offset by a 59% increase in "Other Income" (primarily interest income due to higher rates).
- Expense Increases:
- Sales & Marketing: Increased 11% ($559K) due to higher commissions and marketing for FSMA 204 traceability.
- G&A: Increased 14% ($645K), primarily because the prior year included a $1.175M one-time Employee Retention Credit (ERC) refund that did not recur.
- Cost of Services: Increased 3% ($107K) due to cybersecurity spending and offshore developer headcount.
- Cash Flow: Operating cash flow decreased 21% ($1.9M) primarily due to the absence of the prior year's ERC refund and an increase in accounts receivable.
- Capital Structure: The company terminated its $10M revolving credit facility in March 2024 as it maintained a strong cash position. It also continued the redemption of Series B and B-1 Preferred Stock.
Guidance, Outlook, and Risks
- Regulatory Tailwinds: Management highlights the FDA's FSMA 204(d) rule (effective Jan 2023, compliance deadline Jan 2026) as a primary growth driver for its Traceability Network.
- Dividends: The Board declared a quarterly cash dividend of $0.0165 per share ($0.066 annualized). Future dividends are contingent on earnings and financial condition.
- Share Repurchases: The company has $7.99M remaining under its share repurchase program. No shares were repurchased in the last two quarters of FY2024.
- Risks:
- Key Person Risk: Heavy reliance on CEO Randall K. Fields.
- Regulatory Delays: Potential delays in FSMA 204 compliance deadlines could slow technology adoption.
- Competition: Larger competitors with greater resources could impact pricing and market share.
- Cybersecurity: Risks associated with data breaches and service interruptions.
Investor Verification Checklist
- FSMA 204 Adoption Rate: Verify the actual uptake of the Traceability Network as the 2026 compliance deadline approaches.
- Recurring Revenue Quality: Confirm the sustainability of the 7% revenue growth and the mix of subscription vs. transactional fees.
- Preferred Stock Redemption: Monitor the cash outflow required to complete the three-year redemption of remaining Series B Preferred Stock ($6.6M remaining obligation).
- Interest Income Sustainability: Assess the impact of potential Federal Reserve rate cuts on the company's "Other Income," which contributed significantly to net income growth.
- Customer Concentration: While no single customer exceeded 10% of revenue, verify the stability of the top "Hub" retailers.